Angiogenese in der Pathophysiologie und Therapie der Endometriose : Eine experimentelle in vivo Studie am Syrischen Goldhamster

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.22028/D291-21087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds.

  2008cited by this paper
• Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients.

  2007cited by this paper
• Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis.

  2007cited by this paper
• Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation

  2006cited by this paper
• A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

  2006cited by this paper
• Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.

  2006cited by this paper
• Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis

  2006cited by this paper
• Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

  2005cited by this paper
• Angiogenesis in the female reproductive system.

  2005cited by this paper
• In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy.

  2005cited by this paper
• Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.

  2005cited by this paper
• Time course of pelvic endometriotic lesion revascularization in a nude mouse model.

  2005cited by this paper
• Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats.

  2004cited by this paper
• Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib.

  2004cited by this paper
• Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

  2004cited by this paper
• Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer

  2004cited by this paper
• Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

  2004cited by this paper
• Antiangiogenesis therapy for endometriosis.

  2004cited by this paper
• Angiogenese und Endometriose

  2004cited by this paper
• Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer.

  2004cited by this paper
• Expression of angiopoietin 1 and 2 in ectopic endometrium on the chicken chorioallantoic membrane.

  2004cited by this paper
• Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder.

  2004cited by this paper
• Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

  2003cited by this paper
• Sirolimus: a current perspective.

  2003cited by this paper
• Molecular actions of sirolimus: sirolimus and mTor.

  2003cited by this paper
• Antiangiogenic agents are effective inhibitors of endometriosis.

  2003cited by this paper
• Medical Management of Endometriosis: Novel Targets and Approaches towards the Development of Future Treatment Regimes

  2003cited by this paper
• Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane.

  2003cited by this paper
• The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation.

  2003cited by this paper
• Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.

  2003cited by this paper
• Viewing the Microcirculation through the Window: Some Twenty Years Experience with the Hamster Dorsal Skinfold Chamber

  2002cited by this paper
• The Antiangiogenic Agents SU5416 and SU6668 Increase the Antitumor Effects of Fractionated Irradiation

  2002cited by this paper
• Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

  2002cited by this paper
• Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis

  2002cited by this paper
• Mechanisms of normal and tumor-derived angiogenesis.

  2002cited by this paper
• Angiotensinogen and Its Cleaved Derivatives Inhibit Angiogenesis

  2002cited by this paper
• Angiogenic Factors in Endometriosis

  2002cited by this paper
• Increased Expression of Cyclooxygenase‐2 in Local Lesions of Endometriosis Patients

  2002cited by this paper
• SU6668, a multitargeted angiogenesis inhibitor.

  2001cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001cited by this paper
• [The results of GnRH analog treatment of endometriosis].

  2001cited by this paper
• Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti‐angiogenesis in vivo

  2001cited by this paper
• Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis

  2001cited by this paper
• Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis.

  2001cited by this paper
• Expression of angiogenic factors in extrapelvic endometriosis.

  2001cited by this paper
• Peritoneal endometriosis: validation of an in-vivo model.

  2001cited by this paper
• Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane.

  2001cited by this paper
• Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis.

  2001cited by this paper
• Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis.

  2001cited by this paper
• SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

  2000cited by this paper
• Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

  2000cited by this paper
• Characterization and prevention of phototoxic effects in intravital fluorescence microscopy in the hamster dorsal skinfold model

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis.

  2000cited by this paper
• Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium.

  2000cited by this paper
• Fluorescence diagnosis of endometriosis on the chorioallantoic membrane using 5-aminolaevulinic acid.

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

  2000cited by this paper
• Invasive Capacity of Heterotopic Endometrium

  2000cited by this paper
• Striated muscle microvascular response to silver implants: A comparative in vivo study with titanium and stainless steel.

  2000cited by this paper
• Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.

  2000cited by this paper
• Prevalence of Endometriosis in Ovarian Cancer

  2000cited by this paper
• Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta.

  2000cited by this paper
• The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure.

  2000cited by this paper
• Medical treatment of endometriosis.

  1999cited by this paper
• Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis.

  1999cited by this paper
• Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

  1999cited by this paper
• Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.

  1999cited by this paper
• Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis.

  1999cited by this paper
• Peritoneal endometriotic lesions differentially express a haptoglobin-like gene.

  1999cited by this paper
• Surface cooling inhibits tumor necrosis factor-alpha-induced microvascular perfusion failure, leukocyte adhesion, and apoptosis in the striated muscle.

  1999cited by this paper
• Quantitative assessment of angiogenesis and osteogenesis after transplantation of bone: comparison of isograft and allograft bone in mice.

  1999cited by this paper
• A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemia.

  1999cited by this paper
• Role of TNF-α in Local Surgical Trauma-Induced Microvascular Dysfunction

  1999cited by this paper
• Use of the 10-day-old chick embryo model for studying angiogenesis.

  1999cited by this paper
• Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women.

  1999cited by this paper
• SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

  1999cited by this paper
• Expression of platelet-derived endothelial cell growth factor (PD-ECGF) related to angiogenesis in ovarian endometriosis.

  1999cited by this paper
• The SCID mouse: an experimental model for endometriosis.

  1999cited by this paper
• Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis.

  1998cited by this paper
• Characteristics of histamine‐induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery

  1998cited by this paper
• Importance of E-selectin for firm leukocyte adhesion in vivo.

  1998cited by this paper
• Effects of Environmental Stress on the Architecture and Permeability of the Rat Mesenteric Microvasculature

  1998cited by this paper
• Cytogenetic analysis of cells from endometriotic cysts of the human ovary.

  1998cited by this paper
• A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

  1998cited by this paper
• A correlation of intravital microscopically assessed NADH fluorescence, tissue oxygenation, and organ function during shock and resuscitation of the rat liver.

  1998cited by this paper
• Vascular endothelial growth factor (VEGF) in endometriosis.

  1998cited by this paper
• The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol.

  1998cited by this paper
• Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.

  1998cited by this paper
• Endometriosis and infertility: new concepts.

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.

  1997cited by this paper
• Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.

  1997cited by this paper
• Intravital Fluorescence Microscopy: Impact of Light-induced Phototoxicity on Adhesion of Fluorescently Labeled Leukocytes

  1997cited by this paper
• [Use of a GnRH analogue (leuprorelin) in the therapy of endometriosis].

  1997cited by this paper
• Contribution of Selectins to Leucocyte Sequestration in Pulmonary Microvessels by Intravital Microscopy in Rabbits

  1997cited by this paper
• [Cap image--a new kind of computer-assisted video image analysis system for dynamic capillary microscopy].

  1997cited by this paper
• Cytokine-induced leukocyte rolling in mouse cremaster muscle arterioles in P-selectin dependent.

  1997cited by this paper
• Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

  1997cited by this paper
• Role of leukocyte plugging and edema in skeletal muscle ischemia-reperfusion injury.

  1997cited by this paper

• No citing papers are available for this paper.